Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luspatercept for Chemotherapy-induced Anemia in AML
NCT07663864Phase 2Recruiting
- Sponsor
- Guangdong Second Provincial General Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of luspatercept in Chemotherapy-induced anemia (CIA), sponsored by Guangdong Second Provincial General Hospital. Started Jun 2026; status: recruiting.
02
Drugs
luspatercept
03
Conditions
Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT07663864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07663864.